Next Article in Journal
SPUD qPCR Assay Confirms PREXCEL-Q Software's Ability to Avoid qPCR Inhibition
Previous Article in Journal
Targeting of the Prion Protein to the Cytosol: Mechanisms and Consequences
 
 
Current Issues in Molecular Biology is published by MDPI from Volume 43 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Caister Press.
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Role of GPI-Anchored PrPC in Mediating the Neurotoxic Effect of Scrapie Prions in Neurons

by
Helois E. Radford
and
Giovanna R. Mallucci
*
In vivo models of Neurotoxicity Group, MRC Toxicology Unit, Hodgkin Building, University of Leicester, Lancaster Road, Leicester LE1 9EH, UK
*
Author to whom correspondence should be addressed.
Curr. Issues Mol. Biol. 2010, 12(2), 119-128; https://doi.org/10.21775/cimb.012.119
Submission received: 5 May 2009 / Revised: 8 May 2009 / Accepted: 9 July 2009 / Published: 18 September 2009

Abstract

There are two central phenomena in prion disease: prion replication and prion neurotoxicity. Underlying them both is the conversion of a host-encoded ubiquitously expressed protein, prion protein (PrPC), into a partially-protease resistant isoform, PrPSc, which accumulates in the brain. PrPSc is associated with both pathology and infectivity. In the absence of PrPC, PrPSc cannot be generated and PrP-null mice do not propagate infectivity or develop pathology on infection with scrapie. However, while PrPC expression is fundamental to both prion infectivity and neurodegeneration, the uncoupling of these processes is a growing concept in the field. This dissociation is evident in subclinical states of prion infection, where PrPSc levels are high in the absence of disease, and in transgenic mice experiments, where, despite extra-neuronal PrPSc accumulation, even in very high amounts, there is no neurotoxicity. Both these models have further implications. Thus depleting PrPC from neurons (but not glia) of prion-infected mice prevents clinical disease, and detaching it from the surface of cells by removing its anchor does the same. The uncoupling toxicity and infectivity has implications for the nature of the neurotoxic species; these mouse models suggest that the site for the generation of this species is intra-neuronal. This review considers the role of neuronal surface-expressed PrPC in mediating toxicity in prion infection, and the dissociation of this from the deposition of PrPSc.
Keywords: prion disease; prion replication; prion neurotoxicity; prion protein; PrP; PrPSc; PrPC prion disease; prion replication; prion neurotoxicity; prion protein; PrP; PrPSc; PrPC

Share and Cite

MDPI and ACS Style

Radford, H.E.; Mallucci, G.R. The Role of GPI-Anchored PrPC in Mediating the Neurotoxic Effect of Scrapie Prions in Neurons. Curr. Issues Mol. Biol. 2010, 12, 119-128. https://doi.org/10.21775/cimb.012.119

AMA Style

Radford HE, Mallucci GR. The Role of GPI-Anchored PrPC in Mediating the Neurotoxic Effect of Scrapie Prions in Neurons. Current Issues in Molecular Biology. 2010; 12(2):119-128. https://doi.org/10.21775/cimb.012.119

Chicago/Turabian Style

Radford, Helois E., and Giovanna R. Mallucci. 2010. "The Role of GPI-Anchored PrPC in Mediating the Neurotoxic Effect of Scrapie Prions in Neurons" Current Issues in Molecular Biology 12, no. 2: 119-128. https://doi.org/10.21775/cimb.012.119

Article Metrics

Back to TopTop